Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Gastrinoma 2Adenoma, Islet Cell 2Zollinger-Ellison Syndrome 1Somatostatinoma 1Rectal Neoplasms 1Rare Diseases 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Insulinoma 1Glucagonoma 1Glioma 1Glioblastoma 1Genetic Diseases, Inborn 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Islet Cell 1Brain Neoplasms 1Astrocytoma 1Adrenocortical Carcinoma 1

Interventions

Cisplatin 7Mitotane 5Doxorubicin 5Etoposide 4relacorilant 2Trastuzumab 2Cytoreduction Surgical Procedures 2tipifarnib 1sodium thiosulfate 1pembrolizumab 1pegfilgrastim 1iodophenyl metomidate 1gossypol acetic acid 1entinostat 1cixutumumab 1avelumab 1Vincristine 1Tamoxifen 1TKM-080301 1Suramin 1Sunitinib 1Streptozocin 1Radiotherapy 1Platinum 1Oxaliplatin 1Observation 1N-Ac-CHAVC-NH2 1N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride 1Microscopy, Electron 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adrenocortical Carcinoma × Streptozocin × Clear all
NCT00094497 2016-09-21

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

Collaborative Group for Adrenocortical Carcinoma Treatment

Phase 3 Completed
304 enrolled 12 charts
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡